| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 53,600 | $30 | $1.8M |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 94,400 | $1 | $377.6K |
| J0897 | Injection, denosumab, 1 mg | 20,040 | $20 | $360.7K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 25,100 | $10 | $276.1K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 19,740 | $10 | $157.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,430 | $30 | $115.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,310 | $80 | $109.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 1,090 | $40 | $47K |
| 99490 | The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the… | 880 | $50 | $40.3K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 470 | $50 | $22.1K |